Board member: Johnson & Johnson will have 100 million COVID-19 vaccine doses by April
Right now, Johnson & Johnson is conducting a large-scale trial to make sure the vaccine is safe and effective.
News 12 Staff
•
Jan 22, 2021, 12:25 PM
•
Updated 1,189 days ago
Share:
More Stories
Nobel in medicine goes to 2 scientists whose work enabled creation of mRNA vaccines against COVID-19
206ds ago1:25
Pharmacies say they have not received orders for newest COVID booster
210ds ago0:21
Biden administration announces $600M to produce COVID tests and will reopen website to order them
217ds ago0:41
Gov. Hochul: Updated COVID-19 vaccine to be available in NY in the coming days
224ds ago2:13
NYSDOH: COVID numbers up with new variant accounting for 17% of new cases
258ds ago2:30
NYSHD: Hospitalizations caused by COVID increase by 22% in a week
266ds agoNobel in medicine goes to 2 scientists whose work enabled creation of mRNA vaccines against COVID-19
206ds ago1:25
Pharmacies say they have not received orders for newest COVID booster
210ds ago0:21
Biden administration announces $600M to produce COVID tests and will reopen website to order them
217ds ago0:41
Gov. Hochul: Updated COVID-19 vaccine to be available in NY in the coming days
224ds ago2:13
NYSDOH: COVID numbers up with new variant accounting for 17% of new cases
258ds ago2:30
NYSHD: Hospitalizations caused by COVID increase by 22% in a week
266ds agoJohnson & Johnson is planning to have enough COVID-19 vaccines for 100 million
Americans by April if its clinical
trial works out.
Right now, Johnson & Johnson is conducting a
large-scale trial to make sure the vaccine is safe and effective.
Dr.
Anthony Fauci says the company is
expected to seek emergency use authorization from the FDA in the next week or
two.
Unlike
the Pfizer and Moderna vaccines, Johnson & Johnson's vaccine is a single
shot and doesn't need to be stored as cold.
